vs
Easterly Government Properties, Inc.（DEA）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Easterly Government Properties, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$91.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 1.5%，领先382.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 16.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.6%）
Easterly Government Properties是一家总部位于美国的房地产投资信托企业，主营收购、开发及运营主要出租给美国联邦政府机构的关键任务类商业地产，资产涵盖办公空间、医疗设施、安全专用场地等，服务美国本土多个核心市场的政府客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
DEA vs RIGL — 直观对比
营收规模更大
DEA
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出4.8%
16.4%
净利率更高
RIGL
高出382.5%
1.5%
两年增速更快
RIGL
近两年复合增速
9.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.5M | $69.8M |
| 净利润 | $1.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 1.5% | 384.0% |
| 营收同比 | 16.4% | 21.2% |
| 净利润同比 | -56.9% | 1769.2% |
| 每股收益（稀释后） | $0.36 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DEARIGL
| Q1 26 | $91.5M | — | ||
| Q4 25 | $87.0M | $69.8M | ||
| Q3 25 | $86.2M | $69.5M | ||
| Q2 25 | $84.2M | $101.7M | ||
| Q1 25 | $78.7M | $53.3M | ||
| Q4 24 | $78.3M | $57.6M | ||
| Q3 24 | $74.8M | $55.3M | ||
| Q2 24 | $76.2M | $36.8M |
净利润DEARIGL
| Q1 26 | $1.4M | — | ||
| Q4 25 | $4.6M | $268.1M | ||
| Q3 25 | $1.2M | $27.9M | ||
| Q2 25 | $4.1M | $59.6M | ||
| Q1 25 | $3.1M | $11.4M | ||
| Q4 24 | $5.5M | $14.3M | ||
| Q3 24 | $4.9M | $12.4M | ||
| Q2 24 | $4.6M | $-1.0M |
毛利率DEARIGL
| Q1 26 | — | — | ||
| Q4 25 | 77.3% | 91.5% | ||
| Q3 25 | 76.0% | 93.2% | ||
| Q2 25 | 77.2% | 95.6% | ||
| Q1 25 | 77.4% | 91.7% | ||
| Q4 24 | 76.1% | 89.9% | ||
| Q3 24 | 77.7% | 85.5% | ||
| Q2 24 | 76.2% | 92.4% |
营业利润率DEARIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% |
净利率DEARIGL
| Q1 26 | 1.5% | — | ||
| Q4 25 | 5.3% | 384.0% | ||
| Q3 25 | 1.4% | 40.2% | ||
| Q2 25 | 4.8% | 58.6% | ||
| Q1 25 | 4.0% | 21.5% | ||
| Q4 24 | 7.0% | 24.9% | ||
| Q3 24 | 6.5% | 22.5% | ||
| Q2 24 | 6.0% | -2.8% |
每股收益（稀释后）DEARIGL
| Q1 26 | $0.36 | — | ||
| Q4 25 | $0.09 | $14.11 | ||
| Q3 25 | $0.02 | $1.46 | ||
| Q2 25 | $0.09 | $3.28 | ||
| Q1 25 | $0.07 | $0.63 | ||
| Q4 24 | $0.13 | $0.82 | ||
| Q3 24 | $0.11 | $0.70 | ||
| Q2 24 | $0.11 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.3B | $391.5M |
| 总资产 | $3.4B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DEARIGL
| Q1 26 | $2.0M | — | ||
| Q4 25 | $23.4M | $155.0M | ||
| Q3 25 | $4.4M | $137.1M | ||
| Q2 25 | $4.7M | $108.4M | ||
| Q1 25 | $8.5M | $77.1M | ||
| Q4 24 | $19.4M | $77.3M | ||
| Q3 24 | $31.2M | $61.1M | ||
| Q2 24 | $14.8M | $49.1M |
总债务DEARIGL
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $52.5M | ||
| Q3 25 | $1.6B | $60.0M | ||
| Q2 25 | $1.7B | $60.0M | ||
| Q1 25 | $1.6B | $60.0M | ||
| Q4 24 | $1.6B | $60.0M | ||
| Q3 24 | $1.5B | $60.0M | ||
| Q2 24 | $1.4B | $60.0M |
股东权益DEARIGL
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $391.5M | ||
| Q3 25 | $1.3B | $117.6M | ||
| Q2 25 | $1.3B | $81.9M | ||
| Q1 25 | $1.3B | $18.6M | ||
| Q4 24 | $1.3B | $3.3M | ||
| Q3 24 | $1.3B | $-14.6M | ||
| Q2 24 | $1.3B | $-29.9M |
总资产DEARIGL
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $513.6M | ||
| Q3 25 | $3.4B | $242.5M | ||
| Q2 25 | $3.4B | $206.7M | ||
| Q1 25 | $3.2B | $176.0M | ||
| Q4 24 | $3.2B | $164.0M | ||
| Q3 24 | $3.1B | $139.4M | ||
| Q2 24 | $3.0B | $128.4M |
负债/权益比DEARIGL
| Q1 26 | — | — | ||
| Q4 25 | 1.26× | 0.13× | ||
| Q3 25 | 1.23× | 0.51× | ||
| Q2 25 | 1.29× | 0.73× | ||
| Q1 25 | 1.20× | 3.23× | ||
| Q4 24 | 1.21× | 18.25× | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DEARIGL
| Q1 26 | — | — | ||
| Q4 25 | $259.2M | $22.0M | ||
| Q3 25 | $155.0M | $24.0M | ||
| Q2 25 | $38.1M | $30.5M | ||
| Q1 25 | $24.2M | $-893.0K | ||
| Q4 24 | $162.6M | $14.5M | ||
| Q3 24 | $57.2M | $21.7M | ||
| Q2 24 | $57.0M | $302.0K |
资本支出强度DEARIGL
| Q1 26 | 0.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率DEARIGL
| Q1 26 | — | — | ||
| Q4 25 | 56.44× | 0.08× | ||
| Q3 25 | 127.75× | 0.86× | ||
| Q2 25 | 9.36× | 0.51× | ||
| Q1 25 | 7.73× | -0.08× | ||
| Q4 24 | 29.82× | 1.01× | ||
| Q3 24 | 11.76× | 1.75× | ||
| Q2 24 | 12.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DEA
| Rental income | $88.6M | 97% |
| Other | $2.3M | 3% |
| Asset management income | $646.0K | 1% |
RIGL
暂无分部数据
